ロード中...
Statistical considerations for pediatric multidrug–resistant tuberculosis efficacy trials
Inclusion of newly licensed or repurposed drugs in regimens to treat children for multidrug–resistant–tuberculosis may lead to therapy that is shorter than traditional regimens and composed only of oral medications. As an all–oral regimen may be more acceptable and have a better safety profile than...
保存先:
| 出版年: | Int J Tuberc Lung Dis |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6086568/ https://ncbi.nlm.nih.gov/pubmed/29665951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.17.0358 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|